C84.Z
Other mature T/NK-cell lymphomas
Clinical Classification Guidelines
Excludes Type 1
- angioimmunoblastic T-cell lymphoma (C86.50)
- blastic NK-cell lymphoma (C86.40)
- enteropathy-type T-cell lymphoma (C86.20)
- extranodal NK-cell lymphoma, nasal type (C86.00)
- hepatosplenic T-cell lymphoma (C86.10)
- primary cutaneous CD30-positive T-cell proliferations (C86.60)
- subcutaneous panniculitis-like T-cell lymphoma (C86.30)
- T-cell leukemia (C91.1-)
Clinical Notes
If T-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
Medical Intelligence & Overview
Other mature T/NK-cell lymphomas belong to a group of rare and diverse types of blood cancers that originate from mature T lymphocytes and natural killer (NK) cells. These lymphomas are characterized by uncontrolled growth of these immune cells, which can lead to various symptoms and complications. The ICD-10 code C84.Z covers these less common forms of T/NK-cell lymphomas that do not fit into more specific categories, providing a way for healthcare providers to classify and track these diagnoses accurately.
Causes & Symptoms
Clinical Causes: The precise causes of other mature T/NK-cell lymphomas are not fully understood. However, certain factors may increase the risk of developing these diseases:
Key Symptoms: The symptoms of these lymphomas can vary widely depending on the specific subtype and the affected organs or tissues. Common signs and symptoms include:
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, imaging tests, and laboratory assessments:
Treatment Protocols: Treatment strategies for mature T/NK-cell lymphomas are individualized based on the specific diagnosis, extent of disease, and patient health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C84.Z a billable ICD-10 code?
Yes, C84.Z is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.Z?
Clinical documentation must specify the nature of Other mature T/NK-cell lymphomas and any associated comorbidities for accurate reporting.
Cite this Clinical Reference